Rosenverse

Log in or create a free Rosenverse account to watch this video.

Log in Create free account

100s of community videos are available to free members. Conference talks are generally available to Gold members.

Digital Medicine Design
Thursday, September 26, 2019 • Enterprise Community
Share the love for this talk
Digital Medicine Design
Speakers: Daniel J. Rosenberg
Link:

Summary

Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES! In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.

Key Insights

  • Digital medicine apps like BlueStar are prescription-only and undergo FDA clearance, making them legally a pharmaceutical class.

  • Only a tiny fraction (about 0.01%) of diabetes apps are FDA-cleared to ensure clinical effectiveness.

  • BlueStar outperforms metformin in lowering A1C by about 2 points through data science and gamification.

  • Bigfoot’s artificial pancreas integrates continuous glucose monitoring with an insulin pump controlled by smartphone, allowing personalized insulin dosing.

  • Medical UX design involves multi-actor systems including patients, caregivers, doctors, payers, pharmacies, and must consider HIPAA regulations.

  • The onboarding and provisioning processes in medical software are far more complex than in enterprise software due to prescriptions, insurance, and regulatory needs.

  • Safety is always the top design priority in digital medicine, followed by privacy and usability.

  • FDA agile process is highly regulated and closer to waterfall with strong documentation and traceability requirements, especially for higher-risk devices.

  • Contextual data like elevation, temperature, and activity levels can personalize insulin dosing algorithms in digital medicine products.

  • User retention issues in medical apps can sometimes mean success, as patients stop using the app after achieving stable health control.

Notable Quotes

"Digital medicine apps are legally considered a pharmaceutical, available by prescription only."

"About 200,000 digital health products exist, but only 1% of 1% have FDA clearance for accuracy."

"BlueStar lowered users' A1C by 2 points, outperforming the most common drug metformin which averages 1.5."

"If the phone dies, Bigfoot’s insulin pump continues working independently, but without new data input."

"You have to keep the injection sites moving because of scar tissue, adding to the body hacking complexity."

"Safety is your number one concern, privacy is your number two, and usability is number three."

"A lot of these companies have founders or investors who are themselves doctors or diabetic patients."

"Design history files must document every design decision for FDA audits—it's far more rigorous than typical usability tests."

"The FDA-approved agile process is more like a controlled waterfall with strict traceability, especially for Class 3 devices."

"If patients stop using the app because they’ve got their health under control, that’s like a dating app success — they got married, not that the app failed."

Ask the Rosenbot
Jane Davis
Strategic Shifts and Innovations in User Research: Navigating Challenges and Opportunities
2025 • Advancing Research 2025
Gold
Sara Asche Anderson
Not Your Ordinary Re-Brand: Design's Path to Driving Customer Obsession at Best Buy
2024 • Enterprise Experience 2020
Gold
Louis Rosenfeld
Opening Remarks
2023 • DesignOps Summit 2023
Gold
Sarah Sgarlato Pierini
From Passion to Execution: A Story of Evolving Research Maturity at LinkedIn
2022 • DesignOps Summit 2022
Gold
Sheryl Cababa
Expanding Your Design Lens with Systems Thinking
2023 • Enterprise Community
Yunyan Li
UX Best Practices
2021 • Design at Scale 2021
Gold
Catt Small
What's Next for ICs: Exploring Staff and Principal Designer Roles
2024 • Rosenfeld Community
Bria Alexander
Charting the future of DesignOps: A community workshop
2024 • DesignOps Community
Russ Unger
Getting Out from Under Everyone: How to Escape the Paralysis of Getting Started
2016 • Enterprise UX 2016
Gold
Frances Yllana
The Big Question about Impact: A Panel Discussion
2024 • DesignOps Summit 2024
Gold
James Lang
Hopeful Futures for UX Research
2026 • Rosenfeld Community
Satyam Kantamneni
Do You Have an Experience Vision?
2023 • Enterprise Community
Farid Sabitov
Theme Four Intro
2022 • DesignOps Summit 2022
Gold
Jen van der Meer
Service design performs value
2025 • Advancing Service Design 2025
Conference
Chris Geison
What's Next for Research?
2021 • Advancing Research Community
Husani Oakley
Theme Two Intro
2023 • Enterprise UX 2023
Gold

More Videos

Sam Proulx

"Nothing about us without us."

Sam Proulx

Accessibility: An Opportunity to Innovate

November 16, 2022

Sarah Brooks

"We can’t predict the future, but we can learn how to think about the future systematically."

Sarah Brooks

Theme 3 Intro

December 10, 2021

Louis Rosenfeld

"Our strong UX process keeps product focused and bias-free as we design together."

Louis Rosenfeld

Founder’s Welcome

December 6, 2022

Rachel Posman

"The most powerful word in the design ops vocabulary is no."

Rachel Posman John Calhoun

"Ask Me Anything" with Rachel Posman and John Calhoun, Authors of the Upcoming Rosenfeld Book, The Design Conductors

September 25, 2024

Abbey Smalley

"59% of roles were onsite focused in 2023, showing a shift back post-pandemic, but remote roles still exist with some location preferences."

Abbey Smalley

Today’s Design Ops and Programs Landscape & Career Paths

October 4, 2023

Maverick Chan

"Using tools like 11 Labs, we instantly generated voices with emotion and appropriate cadence for characters."

Maverick Chan Claire Lin

From Doodle to Demo: AI as Our Storytelling Partner

October 23, 2025

Kristin Skinner

"The biggest challenges are lack of visibility into the work, proving value, and coordinating and collaborating across teams."

Kristin Skinner

Theme 1 Intro

September 29, 2021

Ruzanna Rozman

"Developing team flow is a lot like dating—you have to nurture it, build instinct, and practice."

Ruzanna Rozman

Getting in Flow with Your Team

January 8, 2024

Patrizia Bertini

"DesignOps should be the bridge between business and designers, translating design’s value in business language."

Patrizia Bertini

DesignOps + KPIs = Measure your Impact!

January 8, 2024